Pro Vise Management Group, LLC Merck & Co., Inc. Transaction History

Pro Vise Management Group, LLC

  • $1.14 Billion
  • Q4 2024

A detailed history of Pro Vise Management Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 8,034 shares of MRK stock, worth $721,131. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,034
Previous 9,347 14.05%
Holding current value
$721,131
Previous $1.06 Million 24.69%
% of portfolio
0.07%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$96.31 - $114.76 $126,455 - $150,679
-1,313 Reduced 14.05%
8,034 $799,000
Q3 2024

Nov 12, 2024
BUY
$111.15 - $128.97 $21,451 - $24,891
193 Added 2.11%
9,347 $1.06 Million
Q2 2024

Aug 12, 2024
SELL
$123.8 - $132.96 $4,456 - $4,786
-36 Reduced 0.39%
9,154 $1.13 Million
Q1 2024

May 09, 2024
SELL
$113.24 - $131.95 $489,649 - $570,551
-4,324 Reduced 32.0%
9,190 $1.21 Million
Q4 2023

Feb 09, 2024
BUY
$100.18 - $109.02 $19,935 - $21,694
199 Added 1.49%
13,514 $1.47 Million
Q3 2023

Nov 08, 2023
BUY
$102.95 - $114.33 $80,095 - $88,948
778 Added 6.21%
13,315 $1.37 Million
Q2 2023

Aug 24, 2023
BUY
$108.61 - $118.38 $129,897 - $141,582
1,196 Added 10.55%
12,537 $1.45 Million
Q1 2023

May 05, 2023
BUY
$102.94 - $114.86 $182,409 - $203,531
1,772 Added 18.52%
11,341 $1.21 Million
Q4 2022

Feb 09, 2023
BUY
$87.44 - $112.11 $14,689 - $18,834
168 Added 1.79%
9,569 $1.06 Million
Q3 2022

Nov 09, 2022
BUY
$84.53 - $94.96 $20,625 - $23,170
244 Added 2.66%
9,401 $810,000
Q2 2022

Aug 08, 2022
SELL
$83.49 - $94.64 $146,107 - $165,620
-1,750 Reduced 16.04%
9,157 $835,000
Q1 2022

Apr 27, 2022
SELL
$73.51 - $82.4 $2.04 Million - $2.28 Million
-27,708 Reduced 71.75%
10,907 $895,000
Q4 2021

Jan 18, 2022
SELL
$72.28 - $90.54 $4.65 Million - $5.82 Million
-64,308 Reduced 62.48%
38,615 $2.96 Million
Q3 2021

Oct 20, 2021
SELL
$71.68 - $78.83 $213,534 - $234,834
-2,979 Reduced 2.81%
102,923 $7.73 Million
Q2 2021

Aug 06, 2021
SELL
$70.31 - $77.77 $97,379 - $107,711
-1,385 Reduced 1.29%
105,902 $8.24 Million
Q1 2021

Apr 22, 2021
BUY
$68.86 - $81.11 $1.6 Million - $1.89 Million
23,306 Added 27.75%
107,287 $8.27 Million
Q4 2020

Jan 19, 2021
BUY
$71.77 - $79.65 $4.36 Million - $4.84 Million
60,807 Added 262.39%
83,981 $6.87 Million
Q2 2020

Aug 07, 2020
SELL
$70.42 - $80.13 $118,023 - $134,297
-1,676 Reduced 6.74%
23,174 $1.79 Million
Q1 2020

May 07, 2020
SELL
$63.36 - $87.82 $34,467 - $47,774
-544 Reduced 2.14%
24,850 $1.91 Million
Q4 2019

Feb 11, 2020
BUY
$77.58 - $87.54 $10,861 - $12,255
140 Added 0.55%
25,394 $2.31 Million
Q3 2019

Nov 13, 2019
SELL
$76.08 - $82.93 $42,833 - $46,689
-563 Reduced 2.18%
25,254 $2.13 Million
Q2 2019

Aug 09, 2019
SELL
$69.84 - $81.59 $154,555 - $180,558
-2,213 Reduced 7.9%
25,817 $2.17 Million
Q1 2019

May 13, 2019
SELL
$69.58 - $79.36 $240,677 - $274,506
-3,459 Reduced 10.98%
28,030 $2.33 Million
Q3 2018

Nov 05, 2018
BUY
$57.69 - $67.84 $23,076 - $27,136
400 Added 1.29%
31,489 $2.23 Million
Q2 2018

Aug 13, 2018
SELL
$50.83 - $59.72 $30,498 - $35,832
-600 Reduced 1.89%
31,089 $1.89 Million
Q1 2018

May 09, 2018
SELL
$50.96 - $59.23 $20,384 - $23,692
-400 Reduced 1.25%
31,689 $1.73 Million
Q4 2017

Feb 07, 2018
SELL
$51.62 - $61.64 $284,426 - $339,636
-5,510 Reduced 14.65%
32,089 $1.81 Million
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $2.21 Million - $2.37 Million
37,599
37,599 $2.41 Million

Others Institutions Holding MRK

# of Institutions
3,973
Shares Held
1.86B
Call Options Held
16M
Put Options Held
15M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $227B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email